Sanofi to buy vitamin maker for $543M

In another instance of Big Pharma diversification, Sanofi-Aventis inked a deal to buy Primary Health Care's vitamin-making unit for $543.4 million; it's Australia's largest distributor of nutritional supplements. Release | Report

Suggested Articles

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Intent-driven audiences are inspired to make health-improving changes after a positive online experience. Find out what they’re driven to do.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.